GlassScriptPhysician profile
Amar Parikh
NPI 1801059118
$27,795.97
in general payments reported to CMS, 2019-2025
31 companies · $1,014 in 2025
The $1,014 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $5,047 · 2021: $6,393 · 2022: $1,137 · 2023: $1,566 · 2024: $667 · 2025: $1,014.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,196 · Travel and Lodging: $1,051.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,195.53 |
| Travel and Lodging | $1,051.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $14,842.53 | 2019-2024 | Senza |
| Boston Scientific Corporation | $9,220.00 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Prodigy Surgical Distribution, INC. | $1,440.55 | 2023-2025 | |
| Arthrex, INC. | $270.08 | 2023 | |
| Ferring Pharmaceuticals INC. | $248.07 | 2019-2025 | Euflexxa |
| Abbott Laboratories | $247.41 | 2020-2024 | Proclaim |
| Allergan, INC. | $145.81 | 2019-2022 | |
| Spr Therapeutics, INC | $141.85 | 2024-2025 | Sprint Pns System |
| Saluda Medical Americas, INC. | $136.54 | 2025 | Evoke |
| Scilex Pharmaceuticals INC. | $135.41 | 2022-2025 | |
| Vertex Pharmaceuticals Incorporated | $124.28 | 2024-2025 | |
| Vertos Medical, INC. | $107.71 | 2019-2022 | |
| Globus Medical, INC. | $94.58 | 2025 | Senza |
| Relievant Medsystems, INC. | $94.03 | 2022 | |
| Abbvie INC. | $63.60 | 2022-2023 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $60.09 | 2019 | |
| Pacira Therapeutics, INC. | $53.16 | 2019 | |
| Medtronic USA, INC. | $38.91 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $37.68 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $31.12 | 2024 | |
| Collegium Pharmaceutical, INC. | $29.39 | 2022 | |
| Axonics, INC. | $28.67 | 2024 | Axonics |
| 180 Medical, INC. | $27.69 | 2019 | |
| Foundation Fusion Solutions, LLC | $27.59 | 2020 | |
| Bioventus LLC | $25.56 | 2025 | Xcell |
| Pfizer INC. | $25.24 | 2019 | |
| Medtronic, INC. | $21.84 | 2022 | |
| Ibsa Pharma INC. | $20.69 | 2025 | Tirosint, Licart, Flector |
| Assertio Therapeutics, INC. | $19.75 | 2020 | |
| Depuy Synthes Sales INC. | $18.08 | 2020 | |
| Mirati Therapeutics, INC. | $18.06 | 2024 | Krazati |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amar Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.